Evidence map›Paper›PMID 22466417›Full record

ArticleMolecular pharmacology2012

Influence of the accessory protein SET on M3 muscarinic receptor phosphorylation and G protein coupling.

Violaine Simon, Sukru S Oner, Joelle Cohen-Tannoudji, Andrew B Tobin, Stephen M Lanier

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Violaine SimonUniversity Paris Diderot, Sorbonne Paris Cité, Biologie Fonctionnelle et Adaptative, Centre National de la Recherche Scientifique-Equipe d’Accueil Conventionée 4413, Paris, France.
Sukru S Oner
Joelle Cohen-Tannoudji
Andrew B Tobin
Stephen M Lanier
Délégation Paris 7 · FRSorbonne Paris Cité · FR

Funding

STRUCTURAL ANALYSIS OF THE ALPHA-2 ADRENERGIC RECEPTORR01NS024821 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LANIER, STEPHEN M. · 1994 to 2007
$2.4M
STRUCTURAL ANALYSIS OF THE ALPHA2-ADRENERGIC RECEPTORR29NS024821 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LANIER, STEPHEN M. · 1987 to 1991
–
NIMH NIH HHS MH90531NINDS NIH HHS NS24821NINDS NIH HHS R01 NS024821Wellcome TrustWellcome Trust 047600
6 · The paper itself

Abstract

The proto-oncogene and inhibitor of protein phosphatase 2A (PP2A), SET, interacts with the third intracellular loop of the M3 muscarinic receptor (M3-MR), and SET knockdown with small interfering RNA (siRNA) in Chinese hamster ovary (CHO) cells augments M3-MR signaling. However, the mechanism of this action of SET on receptor signaling has not been defined, and we initiated studies to address this question. Knockdown of SET by siRNA in CHO cells stably expressing the M3-MR did not alter agonist-induced receptor phosphorylation or receptor internalization. Instead, it increased the extent of receptor dephosphorylation after agonist removal by ∼60%. In competition binding assays, SET knockdown increased high-affinity binding of agonist in intact cells and membrane preparations. Glutathione transferase pull-down assays and site-directed mutagenesis revealed a SET binding site adjacent to and perhaps overlapping the G protein-binding site within the third intracellular loop of the receptor. Mutation of this region in the M3-MR altered receptor coupling to G protein. These data indicate that SET decreases M3-MR dephosphorylation and regulates receptor engagement with G protein, both of which may contribute to the inhibitory action of SET on M3-MR signaling.

Indexed as

AnimalsBinding SitesCHO CellsCricetinaeDNA-Binding ProteinsGTP-Binding ProteinsHistone ChaperonesHumansMutagenesis, Site-DirectedMutationPhosphorylationProtein Phosphatase 2Proto-Oncogene MasProto-Oncogene ProteinsReceptor, Muscarinic M3Signal TransductionDNA-Binding ProteinsGTP-Binding ProteinsHistone ChaperonesMAS1 protein, humanProtein Phosphatase 2Proto-Oncogene MasProto-Oncogene ProteinsReceptor, Muscarinic M3SET protein, humanTranscription Factors

Identifiers

PMID22466417
PMCPMC3382831
OpenAlexW2126073677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.